Compile Data Set for Download or QSAR
maximum 50k data
Found 2056 with Last Name = 'lian' and Initial = 'b'
TargetAdenosine receptor A3(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50106541(4-Amino-2-(6-cyclopentylamino-purin-9-yl)-5-hydrox...)
Affinity DataKi:  0.190nMAssay Description:Binding affinity at Mutant (H272E) human adenosine A3 receptor expressed in COS-7 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM25400((2R,3R,4S,5R)-2-[6-(cyclopentylamino)-9H-purin-9-y...)
Affinity DataKi:  0.450nMAssay Description:Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A1 receptor in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50179182((2R,3R,4S,5R)-2-(6-(bicyclo[2.2.1]heptan-7-ylamino...)
Affinity DataKi:  0.480nMAssay Description:Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A1 receptor in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50106541(4-Amino-2-(6-cyclopentylamino-purin-9-yl)-5-hydrox...)
Affinity DataKi:  0.540nMAssay Description:Binding affinity at wild-type Adenosine A3 receptor expressed in COS-7 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(3) dopamine receptor(Homo sapiens)
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50589922(CHEMBL5179436)
Affinity DataKi:  0.770nMAssay Description:Binding affinity to human D3 dopamine receptorMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetAdenosine receptor A1(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50085658((2R,3R,4S,5R)-2-(2-Chloro-6-cyclopentylamino-purin...)
Affinity DataKi:  0.830nMAssay Description:Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A1 receptor in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50106535((2R,3R,4S,5S)-4-Amino-5-hydroxymethyl-2-[6-(3-iodo...)
Affinity DataKi:  0.870nMAssay Description:Binding affinity at wild-type Adenosine A3 receptor expressed in COS-7 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196903(US9212192, 66)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196849(US9212192, 12)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196852(US9212192, 15)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196854(US9212192, 17)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196855(US9212192, 18)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196857(US9212192, 20)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196862(US9212192, 25)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196863(US9212192, 26)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196864(US9212192, 27)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196865(US9212192, 28)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196866(US9212192, 29)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196868(US9212192, 31)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196869(US9212192, 32)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196870(US9212192, 33)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196873(US9212192, 36)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196875(US9212192, 38)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196877(US9212192, 40)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196878(US9212192, 41)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196879(US9212192, 42)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196881(US9212192, 44)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196885(US9212192, 48)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196886(US9212192, 49)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196887(US9212192, 50)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196888(US9212192, 51)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196890(US9212192, 53)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196891(US9212192, 54)
Affinity DataKi: <1nM ΔG°: <-51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196897(US9212192, 60)
Affinity DataKi:  1nM ΔG°:  -51.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137394(((R)-2-(3H-Indol-3-yl)-1-{3-phenyl-1-[(4-piperidin...)
Affinity DataKi:  1nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137398(((R)-2-(4-Hydroxy-phenyl)-1-{3-phenyl-1-[(4-piperi...)
Affinity DataKi:  1nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137388(((R)-2-Methyl-1-{3-phenyl-1-[(4-piperidin-1-yl-phe...)
Affinity DataKi:  1nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137400(((R)-2-Phenyl-1-{3-phenyl-1-[(4-piperidin-1-yl-phe...)
Affinity DataKi:  1nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50106543(5-[6-(4-Amino-3-iodo-benzylamino)-purin-9-yl]-3,4-...)
Affinity DataKi:  1.20nMAssay Description:Binding affinity at wild-type Adenosine A3 receptor expressed in COS-7 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137392(CHEMBL99195 | [(S)-1-((S)-1-Formyl-3-methylsulfany...)
Affinity DataKi:  1.30nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196880(US9212192, 43)
Affinity DataKi:  1.5nM ΔG°:  -50.4kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
National Institute Of Diabetes And Digestive And Kidney Diseases

Curated by ChEMBL
LigandPNGBDBM50106537(4-[2-Chloro-6-(3-iodo-benzylamino)-purin-9-yl]-2,3...)
Affinity DataKi:  1.60nMAssay Description:Binding affinity at wild-type Adenosine A3 receptor expressed in COS-7 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196899(US9212192, 62)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137389(((R)-3-Methyl-1-{3-phenyl-1-[(4-piperidin-1-yl-phe...)
Affinity DataKi:  2nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196892(US9212192, 55)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137395(CHEMBL170242 | {(S)-1-[(S)-1-Benzyl-2-(4-morpholin...)
Affinity DataKi:  2nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196856(US9212192, 19)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196876(US9212192, 39)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetALK tyrosine kinase receptor(Homo sapiens (Human))
Abbvie

US Patent
LigandPNGBDBM196884(US9212192, 47)
Affinity DataKi:  2nM ΔG°:  -49.7kJ/molepH: 7.4 T: 2°CAssay Description:ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compo...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Amgen

Curated by ChEMBL
LigandPNGBDBM50137393(CHEMBL353725 | {(S)-1-[(S)-1-Benzyl-2-(4-piperidin...)
Affinity DataKi:  2nMAssay Description:Inhibitory activity against recombinant human cathepsin LMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 2056 total ) | Next | Last >>
Jump to: